HN-2201

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameHN-2201
Drug Alias NameHN-2201HN2201
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen MagicRNA Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Provincial Maternal And Child Health Care HospitalShenzhen MagicRNA Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A